Gender dimorphism in aspartame-induced impairment of spatial cognition and insulin sensitivity

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Collison, Kate S ^a   Makhoul, Nadine J ^a   Zaidi, Marya Z ^a   Saleh, Soad M ^a   Andres, Bernard ^a   Inglis, Angela ^a   Al Rabiah, Rana ^a   Al Mohanna, Futwan A ^a,b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTAME; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ESCAPE BEHAVIOR; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAABDOMINAL FAT; LEARNING DISORDER; LONG TERM EXPOSURE; MALE; MAZE TEST; MOUSE; NONHUMAN; REFERENCE MEMORY; SEX DIFFERENCE; SPATIAL MEMORY; WEIGHT GAIN; ANIMAL; BEHAVIOR; BLOOD; BODY WEIGHT; C57BL MOUSE; COGNITION; DIET RESTRICTION; DOSE RESPONSE; DRUG EFFECT; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; SEXUAL DEVELOPMENT; TIME;

CAVIA; DANIO RERIO; MUS; RODENTIA;

ANIMALS; ASPARTAME; BLOOD GLUCOSE; BODY WEIGHT; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; FASTING; FEMALE; INSULIN RESISTANCE; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; SEX CHARACTERISTICS; SPATIAL BEHAVIOR; TIME FACTORS;

EID: 84859256911     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031570     Document Type: Article

References (81)

1. Christian B, McConnaughey K, Bethea E, Brantley S, Coffey A, et al. (2004) Chronic aspartame affects T-maze performance, brain cholinergic receptors and Na+,K+-ATPase in rats. Pharmacol Biochem Behav 78 (1): 121-127.
2. Humphries P, Pretorius E, Naude H, (2008) Direct and indirect cellular effects of aspartame on the brain. Eur J Clin Nutrition 62: 451-462.
3. Blanco M, Casado R, Vázquez F, Pumar JM, (2006) CT and MR imaging findings in methanol intoxication. AJNR Am J Neuroradiol 27 (2): 452-454.
4. Inouye M, Murakami U, (1973) Brain lesions in mouse infants and fetuses induced by monosodium L. aspartate. Congen Anomal 13: 235-244.
5. Arai T, Hasegawa Y, Oki Y, (1992) Changes in hepatic lipogenic enzyme activities in voles and mice treated with monosodium aspartate. Res Vet Sci 53 (2): 247-249.
6. Park CH, Choi SH, Piao Y, Kim S, Lee YJ, et al. (2000) Glutamate and aspartate impair memory retention and damage hypothalamic neurons in adult mice. Toxicol Lett 115 (2): 117-125.
7. Blau N, van Spronsen FJ, Levy HL, (2010) Phenylketonuria. 9750 Lancet 76 pp. 1417-1427.
8. Scriver CR, Byck S, Prevost L, Hoang L, (1996) The phenylalanine hydroxylase locus: a marker for the history of phenylketonuria and human genetic diversity. PAH Mutation Analysis Consortium, Ciba Found Symp 197: 73-90.
9. Griffin RF, Humienny ME, Hall EC, Elsas LJ, (1973) Classic phenylketonuria: heterozygote detection during pregnancy. Am J Hum Genet 25 (6): 646-654.
10. Jagenburg R, Regårdh CG, Rödjer S, (1977) Detection of heterozygotes for phenylketonuria. Total body phenylalanine clearance and concentrations of phenylalanine and tyrosine in the plasms of fasting subjects compared. Clin Chem 23 (9): 1654-1660.
11. Stegink LD, Filer LJ Jr, Bell EF, Ziegler EE, Tephly TR, et al. (1990) Repeated ingestion of aspartame-sweetened beverages: further observations in individuals heterozygous for phenylketonuria. Metabolism 39 (10): 1076-1081.
12. Glushakov AV, Glushakova O, Varshney M, Bajpai LK, Sumners C, et al. (2005) Long-term changes in glutamatergic synaptic transmission in phenylketonuria. Brain 128(Pt 2): 300-307.
13. Liang L, Gu X, Lu L, Li D, Zhang X, (2011) Phenylketonuria-related synaptic changes in a BTBR-Pah(enu2) mouse model. Neuroreport 22 (12): 617-622.
14. Cabib S, Pascucci T, Ventura R, Romano V, Puglisi-Allegra S, (2003) The behavioral profile of severe mental retardation in a genetic mouse model of phenylketonuria. Behav Genet 33 (3): 301-310.
15. Glushakov AV, Dennis DM, Morey TE, Sumners C, Cucchiara RF, et al. (2002) Specific inhibition of N-methyl-D-aspartate receptor function in rat hippocampal neurons by Phenylalaninenylalanine at concentrations observed during phenylketonuria. Mol Psychiatry 7 (4): 359-367.
16. Glushakov AV, Dennis DM, Sumners C, Seubert CN, Martynyuk AE, (2003) Phenylalaninenylalanine selectively depresses currents at glutamatergic excitatory synapses. J Neurosci Res 72 (1): 116-124.
17. Martynyuk AE, Glushakov AV, Sumners C, Laipis PJ, Dennis DM, et al. (2005) Impaired glutamatergic synaptic transmission in the PKU brain. Mol Genet Metab 86 (Suppl 1): S34-42.
18. Riedel G, Platt B, Micheau J, (2003) Glutamate receptor function in learning and memory. Behavioural Brain Res 140: 1-47.
19. Morris RG, (1989) Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. J Neurosci 9 (9): 3040-3057.
20. Yeh GC, Bonhaus DW, McNamara JO, (1990) Evidence that zinc inhibits N-methyl-D-aspartate receptor-gated ion channel activation by noncompetitive antagonism of glycine binding. Mol Pharmacol 38 (1): 14-19.
21. MacDonald JF, Bartlett MC, Mody I, Reynolds JN, Salter MW, (1990) The PCP site of the NMDA receptor complex. Adv Exp Med Biol 268: 27-34.
22. Izquierdo I, (1994) Pharmacological evidence for a role of long-term potentiation in memory. FASEB J 8: 1139-1145.
23. Stegink LD, Pitkin RM, Reynolds WA, Brummel MC, Filer LJ Jr, (1979) Placental transfer of aspartate and its metabolites in the primate. Metabolism 28 (6): 669-676.
24. Pueschel SM, Boylan JM, Jackson BT, Piasecki GJ, (1982) A study of placental transfer mechanisms in nonhuman primates using [14C]phenylalanine. Obstet Gynecol 59 (2): 182-188.
25. Stegink LD, Filer LJ Jr, BakerGL, McDonnell JE, (1981) Letters to the Editor: Aspartame doses for Phenylketonuria. J Nutr 111 (9): 1688-1690.
26. Dow-Edwards DL, Scribani LA, Riley EP, (1989) Impaired performance on odor-aversion testing following prenatal aspartame exposure in the guinea pig. Neurotoxicol Teratol 11 (4): 413-416.
27. Brunner RL, Vorhees CV, Kinney L, Butcher RE, (1979) Aspartame: assessment of developmental psychotoxicity of a new artificial sweetener. Neurobehav Toxicol 1 (1): 79-86.
28. Kim JY, Seo J, Cho KH, (2011) Aspartame-fed zebrafish exhibit acute deaths with swimming defects and saccharin-fed zebrafish have elevation of cholesteryl ester transfer protein activity in hypercholesterolemia, Food Chem Toxicol. 49 (11): 2899-905.
29. Stokes AF, Belger A, Banich MT, Taylor H, (1991) Effects of acute aspartame and acute alcohol ingestion upon the cognitive performance of pilots. Aviat Space Environ Med 62 (7): 648-653.
30. Tilson HA, Hong JS, Sobotka TJ, (1991) High doses of aspartame have no effects on sensorimotor function or learning and memory in rats. Neurotoxicol Teratol 13 (1): 27-35.
31. Gibbs ME, Richdale AL, Ng KT, (1987) Effect of excess intracranial amino acids on memory: a behavioural survey. Neurosci Biobehav Rev 11 (3): 331-339.
32. Remke H, Wilsdorf A, Müller F, (1988) Development of hypothalamic obesity in growing rats. Exp Pathol 33 (4): 223-232.
33. Hermanussen M, García AP, Sunder M, Voight M, Salazar V, et al. (2006) Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite. Eur J Clin Nutr 60 (1): 25-31.
34. Matysková R, Maletínská L, Maixnerová J, Pirník Z, Kiss A, et al. (2008) Comparison of the obesity phenotypes related to monosodium glutamate effect on arcuate nucleus and/or the high fat diet feeding in C57BL/6 and NMRI mice. Physiol Res 57 (5): 727-734.
35. Nemeroff CB, Lipton MA, Kizer JS, (1978) Models of neuroendocrine regulation: use of monosodium glutamate as an investigational tool. Dev Neurosci 1 (2): 102-109.
36. Olney JW, Ho OL, (1970) Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 227: 609-610.
37. Peruzzo B, Pastor FE, Blázquez JL, Schöbitz K, Pelaez B, et al. (2000) A second look at the barriers of the medial basal hypothalamus. Exp Brain Res 132 (1): 10-26.
38. Yu T, Zhao Y, Shi W, Ma R, Yu L, (1997) Effects of maternal oral administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain. Brain Res. 747 (2): 195-206.
39. Joint Food and Agriculture Organization/World Health Organization (FAO/WHO) Expert Committee on Food Additives (JECFA) (1988): L-glutamic acid and its ammonium, calcium, monosodium and potassium salts. WHO Food Additives series 22 97-161 New York Cambridge University Press.
40. Collison KS, Makhoul NJ, Inglis A, Al-Johi M, Zaidi MZ, et al. (2010) Dietary trans-fat combined with monosodium glutamate induces dyslipidemia and impairs spatial memory. Physiol Behav 99 (3): 334-342.
41. Dubovický M, Skultétyová I, Jezová D, (1999) Neonatal stress alters habituation of exploratory behavior in adult male but not female rats. Pharmacol Biochem Behav 64 (4): 681-686.
42. Maiter D, Underwood LE, Martin JB, Koenig JI, (1991) Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats. Endocrinology 128 (2): 1100-1106.
43. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, (1985) Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
44. Morris RJ, (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60.
45. Brody DL, Holtzman DM, (2006) Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury. Exp Neurol 197 (2): 330-340.
46. Andreazzi AE, Scomparin DX, Mesquita FP, Balbo SL, Gravena C, et al. (2009) Swimming exercise at weaning improves glycemic control and inhibits the onset of monosodium L-glutamate-obesity in mice. J Endocrinol 201 (3): 351-9.
47. Potts WJ, Bloss JL, Nutting EF, (1980) Biological properties of aspartame. I. Evaluation of central nervous system effects. Environ Pathol Toxicol 3 (5-6): 341-345.
48. Reynolds WA, Butler V, Lemkey-Johnston N, (1976) Hypothalamic morphology following ingestion of aspartame or MSG in the neonatal rodent and primate: a preliminary report. Toxicol Environ Health 2 (2): 471-80.
49. Yokogoshi H, Roberts CH, Caballero B, Wurtman RJ, (1984) Effects of aspartame and glucose administration on brain and plasma levels of large neutral amino acids and brain 5-hydroxyindoles. Am J Clin Nutr 40 (1): 1-7.
50. Levy HL, (1999) Phenylketonuria: old disease, new approach to treatment [editorial]. Proc Natl Acad Sci USA 96, 1811-1813.
51. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC, (1995) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, New York: McGraw-Hill 1(7), 1015-1075.
52. Tourian A, Treiman DM, Carr JS, (1972) Developmental biology of hepatic phenylalanine hydroxylase activity in foetal and neonatal rats synchronized as to conception. Biochem Biophys Acta. 279(3), 484-490.
53. Dhondt JL, Dautrevaux M, Biserte G, Farriaux JP, (1979) Developmental aspect of phenylalanine hydroxylase in the rat - hormonal influences. Mech Ageing Dev 10(3-4), 219-224.
54. Faust DM, Catherin A-M, Barbaux S, Belkadi L, Imaizumi-Scherrer T, et al. (1996) The Activity of the Highly Inducible Mouse Phenylalanine Hydroxylase Gene Promoter Is Dependent upon a Tissue-Specific, Hormone-Inducible Enhancer. Mol Cell Biol 16 (6); 3125-3137.
55. Cabib S, Pascucci T, Ventura R, Romano V, Puglisi-Allegra S, (2003) The behavioral profile of severe mental retardation in a genetic mouse model of phenylketonuria. Behav Genet. 33 (3): 301-10.
56. Zagreda L, Goodman J, Druin DP, McDonald D, Diamond A, (1999) Cognitive deficits in a genetic mouse model of the most common biochemical cause of human mental retardation. J Neurosci. 19 (14): 6175-82.
57. Gassió R, Artuch R, Vilaseca MA, Fusté E, Boix C, et al. (2005) Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population. Dev Med Child Neurol. 47 (7): 443-8.
58. Janzen D, Nguyen M, (2010) Beyond executive function: non-executive cognitive abilities in individuals with PKU. Mol Genet Metab. 99 (Suppl 1): S47-51.
59. Ercal N, Aykin-Burns N, Gurer-Orhan H, McDonald JD, (2002) Oxidative stress in a phenylketonuria animal model. Free Radic Biol Med 32: 906-911.
60. Mazzola PN, Terra M, Rosa AP, Mescka CP, Moraes TB, et al. (2011) Regular exercise prevents oxidative stress in the brain of hyperphenylalaninemic rats. Metab Brain Dis 26 (4): 291-7.
61. Whalley LJ, Deary IJ, Appleton CL, Starr JM, (2004) Cognitive reserve and the neurobiology of cognitive aging. Ageing Res Rev. 3 (4): 369-82.
62. Abdel-Salam OM, Salem NA, Hussein JS, (2011) Effect of Aspartame on Oxidative Stress and Monoamine Neurotransmitter Levels in Lipopolysaccharide-Treated Mice. Neurotox Res. Aug 6. [Epub ahead of print].
63. Wolff M, Savova M, Malleret G, Segu L, Buhot MC, (2002) Differential learning abilities of 129T2/Sv and C57BL/6J mice as assessed in three water maze protocols. Behav Brain Res 136 (2): 463-474.
64. Wolfer DP, Stagljar-Bozicevic M, Errington ML, Lipp HP, (1998) Spatial memory and learning in transgenic mice: fact or artifact? News Physiol Sci 13: 118-123.
65. Devan BD, White NM, (1999) Parallel information processing in the dorsal striatum: relation to hippocampal function. J Neurosci 19 (7): 2789-2798.
66. Hostetter G, Thomas GJ, (1967) Evaluation of enhanced thigmotaxis as a condition of impaired maze learning by rats with hippocampal lesions. J Comp Physiol Psychol 63 (1): 105-110.
67. Cain DP, Saucier D, Hall J, Hargreaves EL, Boon F, (1996) Detailed behavioral analysis of water maze acquisition under APV or CNQX: contribution of sensorimotor disturbances to drug-induced acquisition deficits. Behav Neurosci 110 (1): 86-102.
68. Saucier D, Hargreaves EL, Boon F, Vanderwolf CH, Cain DP, (1996) Detailed behavioral analysis of water maze acquisition under systemic NMDA or muscarinic antagonism: nonspatial pretraining eliminates spatial learning deficits. Behav Neurosci 110 (1): 103-116.
69. Mahalik MP, Gautieri RF, (1984) Reflex responsiveness of CF-1 mouse neonates following maternal aspartame exposure. Res Commun Psychol Psychiatry Behav 9: 385-403.
70. McAnulty PA, Collier MJ, Enticott J, Tesh JM, Mayhew DA, et al. (1989) Absence of developmental effects in CF-1 mice exposed to aspartame in utero. Fundam Appl Toxicol 13 (2): 296-302.
71. Cox DJ, Kovatchev BP, Gonder-Frederick LA, Summers KH, McCall A, et al. (2005) Relationship between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 28 (1), 71-77.
72. Ishii H, Koshimizu T, Usami S, Fujimoto T, (1981) Toxicity of aspartame and its diketopiperazine for Wistar rats by dietary administration for 104 weeks, Toxicology 21 (2): 91-94.
73. Yang Q, (2010) Gain weight by "going diet? " Artificial sweeteners and the neurobiology of sugar cravings: Neuroscience, Yale J Biol Med 83 (2): 101-108.
74. Fowler SP, Williams K, Resendez RG, Hunt KJ, Hazuda HP, et al. (2008) Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain. Obesity (Silver Spring Md.) 16: 1894-1900.
75. Ferland A, Brassard P, Poirier P, (2007) Is aspartame really safer in reducing the risk of hypoglycemia during exercise in patients with type 2 diabetes?. Diabetes Care 30 (7): e59.
76. Hlinák Z, Gandalovicová D, Krejcí I, (2005) Behavioral deficits in adult rats treated neonatally with glutamate. Neurotoxicol Teratol 27 (3): 465-473.
77. Nascimento Curi CM, Marmo MR, Egami M, Ribeiro EB, Andrade IS, et al. (1991) Effect of monosodium glutamate treatment during neonatal development on lipogenesis rate and lipoprotein lipase activity in adult rats. Biochem Int. 24 (5): 927-35.
78. Yaffe K, (2007) Metabolic syndrome and cognitive decline. Curr Alzheimer Res; 4 (2): 123-6.
79. Janus C, (2004) Search strategies used by APP transgenic mice during navigation in the Morris water maze. Learn Mem; 11 (3): 337-46.
80. Jurdak N, Lichtenstein AH, Kanarek RB, (2008) Diet-induced obesity and spatial cognition in young male rats. Nutr Neurosci. 11 (2): 48-54.
81. Benice TS, Rizk A, Kohama S, Pfankuch T, Raber J, (2006) Sex-differences in age-related cognitive decline in C57BL/6J mice associated with increased brain microtubule-associated protein 2 and synaptophysin immunoreactivity. Neuroscience 137 (2): 413-23.